Results 101 to 110 of about 9,878 (194)
Bipolar Disorders, Volume 28, Issue 5, August 2026.ABSTRACT Objective Bipolar disorder (BD) often emerges during mid‐adolescence and young adulthood, and leads to functional and social impairment, with a prevalence of 0.87% among Dutch youth. Lithium, the first‐line BD maintenance treatment, stabilizes mood, prevents suicide, and is well tolerated, yet its use has declined as long‐term second ...
Ravish N. Gangapersad +8 more
wiley +1 more source
Desvenlafaxine in the treatment of major depressive disorder
Neuropsychiatric Disease and Treatment, 2009 Maria Teresa C Lourenco1, Sidney H Kennedy1,21Department of Psychiatry, University Health Network, Toronto; 2Department of Psychiatry, University of Toronto, Toronto, CanadaAbstract: Major depressive disorder (MDD) is among the most incapacitating ...
Maria Teresa C Lourenco1 +1 more
doaj
The Blue Delirium: Serotonin and Anticholinergic Toxicity in a 95‐Year‐Old Woman
Journal of the American Geriatrics Society, EarlyView.
Camila S. Badell +3 more
wiley +1 more source
Weight‐Lowering Drugs and Natural Female Fertility—A Systematic Review and Meta‐Analysis
Clinical Obesity, Volume 16, Issue 4, August 2026.ABSTRACT Overweight and obesity are global health concerns linked to impaired female fertility. Weight‐lowering drugs are an alternative for achieving weight loss; however, their effect on natural female fertility is unclear. A systematic review and meta‐analysis were conducted to summarise the literature on the effects of weight‐lowering drugs on ...
Shaikha Jabor Alnaimi +4 more
wiley +1 more source
Arthritis Care &Research, Volume 78, Issue 7, Page 860-874, July 2026.Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2230-2238, July 2026.Abstract Aim Individual second‐generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second‐generation antihistamines is associated with the risk of injury during Japan's pollen season. Methods We conducted a
Jumpei Taniguchi +3 more
wiley +1 more source
, 2019 Selective serotonin reuptake inhibitors (SSRIs) are considered to be the first-line pharmaco-logical treatment of anxiety disorders in children and adolescents.
Íris Harpa Stefánsdóttir 1992-
core
Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management—A Narrative Review
CNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.The incidence of PHN is increasing, posing a substantial public health burden. Its pathogenesis involves VZV reactivation, peripheral and central sensitization, and genetic susceptibility, with key risk factors including older age, severe acute pain, extensive rash, immunocompromise, comorbidities, and delayed treatment.
Fei Tang, Fukun Zhao
wiley +1 more source
Brain Aging in Specific Phobia: An ENIGMA‐Anxiety Mega‐Analysis
Human Brain Mapping, Volume 47, Issue 10, July 2026.This ENIGMA‐Anxiety mega‐analysis did not find advanced brain aging across a wide age range in adult participants with specific phobia, compared to controls. However, a robust diagnosis‐by‐age interaction was observed, with greater relative brain age in young adults with formally diagnosed specific phobia.
Kimberly V. Blake +75 more
wiley +1 more source
Pregnancy, Volume 2, Issue 4, July 2026.Abstract Introduction While the strong association of prenatal depression with an increased risk of new cardiovascular disease (CVD) within 24 months postpartum has been demonstrated in two distinct cohorts, it is unclear if treatment of prenatal depression may mitigate this risk.
Christina M. Ackerman‐Banks +3 more
wiley +1 more source